Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Vaccinations01:51

Vaccinations

51.0K
Overview
51.0K
Development of Immunocompetence01:22

Development of Immunocompetence

731
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
731
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K
International Nursing Organizations II01:28

International Nursing Organizations II

1.3K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.3K
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

900
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
900

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Newborns with sickle cell trait have distinct peripheral blood molecular signatures across the first week of life.

Blood. Red cells & iron·2026
Same author

Yellow fever vaccination in healthy Gambian children of different ages to establish safety and immunogenicity of a booster dose: a open-label, non-randomised, single-site, phase 3 vaccine trial.

The Lancet. Infectious diseases·2026
Same author

A multi-omics study reveals pathway-level insights and predictive biomarkers in pediatric TB.

Clinical proteomics·2026
Same author

Population-specific heterogeneity in ontogeny of the broadly-conserved blood transcriptional program during the first week of life.

Nature communications·2026
Same author

Research priorities for improved pandemic and epidemic intelligence.

The Lancet. Global health·2026
Same author

Increase in imported mupirocin-resistant <i>Staphylococcus aureus</i> from the tropics and subtropics: trends in Berlin from 2018 to 2025.

New microbes and new infections·2026

Video Experimental Relacionado

Updated: Jan 4, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.5K

La inmunización: avances vitales, agenda sin concluir

Peter Piot1, Heidi J Larson2,3,4, Katherine L O'Brien5

  • 1Office of the Director, Vaccine Centre and Vaccine Confidence Project, London School of Hygiene & Tropical Medicine, London, UK. peter.piot@lshtm.ac.uk.

Nature
|November 8, 2019
PubMed
Resumen

La vacunación salva millones de vidas, pero la cobertura varía significativamente, lo que pone de relieve las necesidades persistentes no satisfechas en los programas mundiales de inmunización. Garantizar el acceso generalizado a las vacunas sigue siendo una prioridad de salud fundamental.

Más Videos Relacionados

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.1K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.1K

Videos de Experimentos Relacionados

Last Updated: Jan 4, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.5K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.1K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.1K

Área de la Ciencia:

  • Salud pública
  • Inmunología
  • Salud global

Sus antecedentes:

  • La vacunación es una piedra angular de la medicina moderna, reduciendo drásticamente la mortalidad por enfermedades infecciosas en niños y adultos.
  • A pesar de los beneficios comprobados, existen diferencias significativas en la cobertura de vacunación a nivel mundial y dentro de las naciones.
  • Los avances científicos ofrecen nuevas posibilidades de vacunación, pero la aplicación se enfrenta a numerosos obstáculos.

Objetivo del estudio:

  • Resaltar el papel crítico de la vacunación en la salud pública.
  • Identificar y abordar las necesidades y desafíos persistentes en la consecución de la cobertura universal de vacunación.
  • Hacer hincapié en la importancia de la inversión continua y la priorización de los programas de inmunización.

Principales métodos:

  • Análisis de los datos de cobertura de vacunación a nivel nacional y subnacional.
  • Revisión de los retos en el desarrollo de vacunas y vías de implementación.
  • Evaluación de los beneficios sociales y de salud de la inmunización.

Principales resultados:

  • La cobertura de vacunación varía considerablemente según las diferentes regiones y poblaciones.
  • Persisten importantes lagunas y necesidades no cubiertas en los programas de inmunización.
  • El viaje desde el descubrimiento de la vacuna hasta la implementación generalizada es complejo, con desafíos financieros, de desarrollo y logísticos.

Conclusiones:

  • La inmunización representa una intervención de salud pública muy eficaz y una buena inversión.
  • Abordar las disparidades en la cobertura de vacunas es crucial para la equidad sanitaria mundial.
  • El compromiso sostenido de los sectores de la investigación, la industria y la salud pública es esencial para priorizar y mejorar los programas de inmunización.